Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance

Stock Information for Antibe Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Antibe Therapeutics Inc.

Antibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act
Antibe to File an Application for an Initial Order Under Companies' Creditors Arrangement Act
Antibe to Present Otenaproxesul PK/PD Results at the ASRA Pain Medicine Meeting
Antibe to Present Otenaproxesul PK/PD Results at the American Academy of Pain Medicine Meeting
Antibe Announces Unfavorable Decision in Arbitration With Nuance Pharma
Antibe Reports Q3 2024 Interim Financial and Operating Results
Antibe Extends Early Warrant Exercise Incentive Program
OTC Markets Group Announces the 2024 OTCQX Best 50

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.